AFP and neoplasm: HCC stands in stark contrast to other tumor types with a historic lack of proven adjuvant therapy despite known risk factors for early recurrence, including higher tumor burden, elevated alpha fetoprotein levels, microvascular invasion, and poor tumor differentiation.